A Review of Newly Diagnosed Glioblastoma. Frontiers in oncology Oronsky, B., Reid, T. R., Oronsky, A., Sandhu, N., Knox, S. J. 2020; 10: 574012

Abstract

Glioblastoma is an aggressive and inevitably recurrent primary intra-axial brain tumor with a dismal prognosis. The current mainstay of treatment involves maximally safe surgical resection followed by radiotherapy over a 6-week period with concomitant temozolomide chemotherapy followed by temozolomide maintenance.This review provides a summary of the epidemiological, clinical, histologic and genetic characteristics of newly diagnosed disease as well as the current standard of care and potential future therapeutic prospects.

View details for DOI 10.3389/fonc.2020.574012

View details for PubMedID 33614476